eli lilly cease and desist letter tirzepatide files complaint with U.S. International Trade Commission surrounding eli lilly tirzepatide cease and

The complete absence of angina and myocardial ischemia reports in the HCP-restricted cohort, alongside neutral signals for acute myocardial infarction, strongly complements the proposed anti-atherosclerotic potential of GLP-1/GIP dual agonism to improve endothelial function and plaque stability (Pujadas et al., 2022)

Diagnostic Interpretation * HbA1c below 5.7%: normal * HbA1c 5.76.4%: prediabetes * HbA1c 6.5% or higher: diabetes mellitus Clinical Uses * Diagnosis of diabetes mellitus * Diagnosis of prediabetes * Monitoring long-term glycemic control * Assessing risk of diabetic complications * Evaluating response to treatment Target Levels For many diabetic patients, the usual target is: * HbA1c below 7% Targets may differ depending on: * Age * Pregnancy * Comorbid illnesses * Risk of hypoglycemia Causes of Falsely Elevated HbA1c * Iron deficiency anemia * Vitamin B12 deficiency * Chronic kidney disease * Reduced red blood cell turnover Causes of Falsely Low HbA1c * Hemolytic anemia * Acute blood loss * Recent blood transfusion * Pregnancy * Increased red blood cell destruction Advantages * Does not require fasting * Reflects chronic glucose control * Convenient for outpatient follow-up Limitations Results may be inaccurate in: * Hemoglobinopathies * Severe anemia * Conditions affecting red blood cell lifespan * HbA1c reflects average glucose over approximately 812 weeks * HbA1c 6.5% is diagnostic for diabetes * It is the standard test for monitoring long-term diabetic control * It is less useful for detecting acute glucose changes or hypoglycemia episodes To view or add a comment, sign in HbA1c Definition HbA1c (glycated hemoglobin) is a laboratory test that measures the percentage of hemoglobin attached to glucose

A thyroid nodule might be completely benign and unrelated to C-cells

Drug trial snapshot: Ozempic

Clin Pharmacokinet (2016) 55(6):65772